-
Pfizer's drug tremelimumab and Bristol-Myers Squibb's ipilimumab are antibodies to a protein called CTLA-4 (cytotoxic T-lymphocyte antigen-4) that acts as an emergency brake to prevent killer T cells from attacking healthy tissue.
FORBES: Targeting Melanoma
-
Those drugs aim to improve on current treatment regimens based on the immune protein alpha interferon--which often don't work and have an array of nasty side effects.
FORBES: Magazine Article
-
It wasn't until 2001 that some experts acknowledged that a low-carb, high-protein diet may have merit.
FORBES: The Atkins Guide To Stock Picking
-
Patients whose cancers are churning out the Sparc protein usually have a worse prognosis than those who aren't Sparc-positive, but with Abraxane they may do just as well, Soon-Shiong argues.
FORBES: Patrick Soon-Shiong and one of cancer's biggest riddles.
-
Other researchers had identified several related protein fragments, called beta-amyloids, inside the amyloid plaques, but they didn't know which proteins were the bad ones.
FORBES: Magazine Article
-
Other researchers had identified several related protein fragments, called beta-amyloid, inside the amyloid plaques, but they didn't know which proteins were the bad ones.
FORBES: Magazine Article
-
While I don't advocate an ultra low-fat diet, because fat has more than double the calories per gram of either protein or carbohydrates, it is the simplest way to cut calories.
CNN: How can I maintain my energy level for sports while on a diet?